\addvspace {10\p@ }
\contentsline {table}{\numberline {1.1}{\ignorespaces Affymetrix Human Gene 2.1 ST Array Strip design specifications.}}{13}{table.1.1}
\addvspace {10\p@ }
\addvspace {10\p@ }
\addvspace {10\p@ }
\contentsline {table}{\numberline {4.1}{\ignorespaces Overview of control probesets on the Affymetrix Human Gene 2.1 ST Array Strip}}{32}{table.4.1}
\contentsline {table}{\numberline {4.2}{\ignorespaces Number of control probes and probesets on the Affymetrix Human Gene 2.1 ST Array Strip}}{34}{table.4.2}
\contentsline {table}{\numberline {4.3}{\ignorespaces The confusion matrix cross-classifies the predicted outcome Log2 intensity $\geq $ threshold versus the true class of probes.}}{57}{table.4.3}
\contentsline {table}{\numberline {4.4}{\ignorespaces Percentage of 'present calls' at probe level.}}{70}{table.4.4}
\contentsline {table}{\numberline {4.5}{\ignorespaces Percentage of 'present calls' at probeset level.}}{70}{table.4.5}
\contentsline {table}{\numberline {4.6}{\ignorespaces Percentage of 'present calls' at probe level in the spike-in controls.}}{71}{table.4.6}
\contentsline {table}{\numberline {4.7}{\ignorespaces Percentage of 'present calls' at probeset level in the spike-in controls.}}{72}{table.4.7}
\contentsline {table}{\numberline {4.8}{\ignorespaces Percentage of 'present calls' at probe level.}}{75}{table.4.8}
\contentsline {table}{\numberline {4.9}{\ignorespaces Percentage of 'present calls' at probeset level.}}{75}{table.4.9}
\contentsline {table}{\numberline {4.10}{\ignorespaces Percentage of 'present calls' at probe level in the spike-in controls.}}{76}{table.4.10}
\contentsline {table}{\numberline {4.11}{\ignorespaces Percentage of 'present calls' at probe level in the spike-in controls.}}{77}{table.4.11}
\addvspace {10\p@ }
\addvspace {10\p@ }
\addvspace {10\p@ }
\contentsline {table}{\numberline {7.1}{\ignorespaces Average above background expression for several genes of interest related to epithelial barrier integrity (TJP1 = ZO-1), mucus expression (MUC2), cell surface receptors (MS4A12), immune signalling (TLR4) and transport (SLC16A1 = MCT1), as well as, marker genes for the presence of macrophages (CD68, ITGAM = CD11b).}}{143}{table.7.1}
\addvspace {10\p@ }
\addvspace {10\p@ }
\addvspace {10\p@ }
\addvspace {10\p@ }
\addvspace {10\p@ }
\addvspace {10\p@ }
